PT  - JOURNAL ARTICLE
AU  - Browne, Sara H.
AU  - Bernstein, Mike
AU  - Bickler, Philip E.
TI  - Accuracy of Samsung Smartphone Integrated Pulse Oximetry Meets Full FDA Clearance Standards for Clinical Use
AID  - 10.1101/2021.02.17.21249755
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.17.21249755
4099  - http://medrxiv.org/content/early/2021/02/18/2021.02.17.21249755.short
4100  - http://medrxiv.org/content/early/2021/02/18/2021.02.17.21249755.full
AB  - Background Pulse oximetry is used as an assessment tool to gauge the severity of COVID-19 infection and identify patients at risk of poor outcomes. 1,2,3,4 The pandemic highlights the need for accurate pulse oximetry, particularly at home, as infection rates increase in multiple global regions including the UK, USA and South Africa 5. Over 100 million Samsung smartphones containing dedicated biosensors (Maxim Integrated Inc, San Jose, CA) and preloaded Apps to perform pulse oximetry, are in use globally. We performed detailed in human hypoxia testing on the Samsung S9 smartphone to determine if this integrated hardware meets full FDA/ISO requirements for clinical pulse oximetry.Methods The accuracy of integrated pulse oximetry in the Samsung 9 smartphone during stable arterial oxygen saturations (SaO2) between 70% and 100% was evaluated in 12 healthy subjects. Inspired oxygen, nitrogen, and carbon dioxide partial pressures were monitored and adjusted via a partial rebreathing circuit to achieve stable target SaO2 plateaus between 70% and 100%. Arterial blood samples were taken at each plateau and saturation measured on each blood sample using ABL-90FLEX blood gas analyzer. Bias, calculated from smartphone readings minus the corresponding arterial blood sample, was reported as root mean square deviation (RMSD).Findings The RMSD of the over 257 data points based on blood sample analysis obtained from 12 human volunteers tested was 2.6%.Interpretation Evaluation of the smartphone pulse oximeter performance is within requirements of <3.5% RMSD blood oxygen saturation (SpO2) value for FDA/ISO clearance for clinical pulse oximetry. This is the first report of smartphone derived pulse oximetry measurements that meet full FDA/ISO accuracy certification requirements. Both Samsung S9 and S10 contain the same integrated pulse oximeter, thus over 100 million smartphones in current global circulation could be used to obtain clinically accurate spot SpO2 measurements to support at home assessment of COVID-19 patients.Competing Interest StatementSara Browne - no competing interests Phil Bickler - no competing interets Mike Bernstein, PhysioMonitor - Physiomonitor specializes in the testing and evaluation of pulse oximeters. In this research PhysioMonitor provided testing expertise funded by NIH R01MH110057S and the non-profit Specialists in Global Health.Clinical TrialThis research does not meet the definition of a clinical trial, human subjects were not prospectively assigned to one or more interventions to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes. This research does involve human research conducted at the UCSF Hypoxia Research Laboratory and followed a protocol approved by UCSF Human Research Protection Program, IRB protocol 10-0043710Funding StatementThe work was funded by a NIH grant supplement R01MH110057-04S to SHB and a Non-Profit, Specialists in Global Health (https://sigh.global/).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UCSF Human Research Protection Program approved the research protocol. The approval number is UCSF HRPP IRB 10-00437.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesFull access to both the reference hemoximeter readings and paired readings from the test device can be obtained by emailing requests to avrcregulatory{at}ucsd.edu